tiprankstipranks

Daniel Billen Insider Profile

4 Followers
Daniel Billen, Director at Aurinia Pharmaceuticals, holds 28.14K shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Daniel Billen Sold $5,252 shares of Aurinia Pharmaceuticals on May 22, 2024 for an estimated value of 30.15K.
tipranks
Daniel Billen

Daniel Billen
Aurinia Pharmaceuticals (AUPH)
Director

Not Ranked
Daniel Billen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$247K
100.00%
A breakdown of Daniel Billen's holdings

Insider Roles

Aurinia Pharmaceuticals
(AUPH)
Director
Roles that Daniel Billen holds in companies

Most Profitable Insider Trade

Stock:
Aurinia Pharmaceuticals
(AUPH)
Rating:Informative Sell
Date:May 22, 2024 - Today
Return:-50.40%
The most profitable trade made by Daniel Billen

Daniel Billen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aurinia Pharmaceuticals
May 22, 2024
Director
Informative Sell
30.15K
$246.80K
Success Rate for
AUPH
0 out of 1 profitable transactions on
AUPH
0%
Average Return for
AUPH
Average return per transaction on
AUPH
-50.40%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 23, 2023
Uninformative Buy
$143.15K
-
$10.80
May 22, 2024
Informative Sell
$30.15K
-
$5.74
-50.40%
List of latest transactions for each holding click on a transaction to see Daniel Billen's performance on stock

Daniel Billen insider profile FAQ

What is the percentage of profitable transactions made by Daniel Billen?
The percentage of profitable transactions made by Daniel Billen is ―.
    What is the average return per transaction made by Daniel Billen?
    The average return per transaction made by Daniel Billen is ―.
      What stocks does Daniel Billen hold?
      Daniel Billen holds: AUPH stocks.
        What was Daniel Billen’s latest transaction?
        Daniel Billen latest transaction was an Informative Sell of $30.15K.
          What was Daniel Billen's most profitable transaction?
          Daniel Billen’s most profitable transaction was an Informative Sell of AUPH stock on May 22, 2024. The return on the trade was -50.40%.
            What is Daniel Billen's role in Aurinia Pharmaceuticals?
            Daniel Billen's role in Aurinia Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.